Christophe Peczynski

Medizinische Hochschule Hannover — Germany

Medicine · Health Sciences

14h-index737citations73works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(42), Acute Lymphoblastic Leukemia research(22), CAR-T cell therapy research(17), Renal Transplantation Outcomes and Treatments(16), Acute Myeloid Leukemia Research(7)

Publications73 total

Update on the Phase 2 Part of Kysa-6, an Open-Label, Single-Arm, Multicenter Study of Kyv-101, a Fully Human CD19 Chimeric Antigen Receptor T-cell Therapy in Generalized Myasthenia Gravis
Transplantation and Cellular Therapy·2026
The Berlin-Hannover ICANS severity assessment–a novel bedside test to evaluate CAR T-cell-associated neurotoxicity
Frontiers in Neurology·2026Open Access
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party
Cancers·2025Open Access
Impact of prior B-cell-directed immunotherapy on the outcome of CD19 CAR T-cell therapy in aggressive B-cell lymphoma - an analysis of the EBMT and the GoCART coalition
Blood·2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Bone Marrow Transplantation·2025· 2 citedOpen Access
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party
Bone Marrow Transplantation·2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT
Bone Marrow Transplantation·2025
Graft‐versus‐host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post‐transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation
British Journal of Haematology·2025Open Access
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party
Blood Cancer Journal·2025Open Access
Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
HemaSphere·2025· 2 citedOpen Access
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Leukemia·2025· 3 citedOpen Access
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT
Bone Marrow Transplantation·2025· 5 citedOpen Access
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study
Leukemia·2024· 9 cited
Practice Patterns of SGLT2 Inhibitor Use in Stem Cell Transplantation and CART Cell Therapy: A Study from the EBMT Transplant Complications Working Party
Blood·2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
Leukemia·2024· 6 citedOpen Access
Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party
Bone Marrow Transplantation·2024Open Access
How risky is a second allogeneic stem cell transplantation?
Leukemia·2024· 14 citedOpen Access
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party
Bone Marrow Transplantation·2024· 6 citedOpen Access
Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation
Haematologica·2024· 6 citedOpen Access
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Leukemia·2024· 29 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Zinaida Perić(35), Hélène Schoemans(34), Olaf Penack(33), Grzegorz Basak(28), Christian Koenecke(24), Ivan Moiseev(24), Nicolaus Kröger(21), Mohamad Mohty(17), William Boreland(15), Emmanuelle Polge(13), Ibrahim Yakoub‐Agha(12), Myriam Labopin(12), Didier Blaise(12), Arnon Nagler(12), Rafael F. Duarte(11), Matthias Stelljes(10), Peter Dreger(10), Thomas Schroeder(9), Gerald Wulf(9), Fabio Ciceri(9)